(Q46091192)

19 December 2017

title

Leukotriene C4 synthase and ischemic cardiovascular disease and obstructive pulmonary disease in 13,000 individuals (English)

1 reference

19 December 2017

main subject

cardiovascular disease

1 reference

2

1 reference

19 December 2017

Anne Tybjærg-Hansen

series ordinal

3

object named as

Anne Tybjaerg-Hansen

1 reference

19 December 2017

Børge G. Nordestgaard

series ordinal

5

object named as

Børge G Nordestgaard

1 reference

19 December 2017

4

Peer Grande

1 reference

19 December 2017

Jacob J Freiberg

series ordinal

1

object named as

Jacob J Freiberg

1 reference

19 December 2017

publication date

1 April 2009

1 reference

19 December 2017

Journal of Molecular and Cellular Cardiology

published in

1 reference

19 December 2017

volume

46

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

579-586

1 reference

19 December 2017

Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Differential leukotriene constrictor responses in human atherosclerotic coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Promoter polymorphism influences the effect of dexamethasone on transcriptional activation of the LTC4 synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Association between a leukotriene C4 synthase gene promoter polymorphism and coronary artery calcium in young women: the Muscatine Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Nonfasting triglycerides and risk of ischemic stroke in the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Genetically elevated C-reactive protein and ischemic vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Stroke case fatality in Denmark from 1977 to 1992: the Copenhagen City Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Comparison of clinical and neuroradiological findings in first-ever stroke. A population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Acute ischemic coronary artery disease and ischemic stroke: similarities and differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Cysteinyl leukotriene receptor 1 gene variation and risk of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Association of four-locus gene interaction with aspirin-intolerant asthma in Korean asthmatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Leukotriene B5 is formed in human neutrophils after dietary supplementation with icosapentaenoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

A critique of paradoxes in current advice on dietary lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Biochemistry and physiology of n-3 fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Leukotriene D4 upregulates eosinophil adhesion via the cysteinyl leukotriene 1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Asthma. From bronchoconstriction to airways inflammation and remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Exhaled leukotrienes and prostaglandins in COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Leukotriene E(4) in urine in patients with asthma and COPD--the effect of smoking habit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

Long-term montelukast therapy in moderate to severe COPD--a preliminary observation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.01.002

10.1016/J.YJMCC.2009.01.002

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017